Results 171 to 180 of about 30,301 (244)

Melphalan improves toxicity of arsenic trioxide in adult T-cell leukemia/lymphoma cells. [PDF]

Biochem Biophys Rep
Khodadadi F, Sadeghian MH, Delbari Z, Kazemi M, Koohpaykar H, Rassouli FB.   +5 more
europepmc   +1 more source

Salinomycin Sensitizes Melanoma Spheroids Containing Slow-Cycling Cells to the Effects of Arsenic Trioxide [PDF]

, 2014
Norihisa ISHIKAWA, Mayuko Takahashi, Natsuko Noguchi, Motomu Manabe   +3 more
openalex  

Successful Outcome of Acute Promyelocytic Leukemia Complicated by Bone Marrow Necrosis and Posterior Reversible Encephalopathy Syndrome, During Treatment With an All-Trans Retinoic Acid Plus Arsenic Trioxide-Based Regimen. [PDF]

Cureus
Venou TM, Mainou M, Voura K, Mbonde Mouangue ES, Flaris N, Vlachaki E.   +5 more
europepmc   +1 more source

RETRACTION: Combined Anticancer Effects of Simvastatin and Arsenic Trioxide on Prostate Cancer Cell Lines via Downregulation of the VEGF and OPN Isoforms Genes. [PDF]

J Cell Mol Med
europepmc   +1 more source

Silencing NRF2 enhances arsenic trioxide-induced ferroptosis in hepatocellular carcinoma cells. [PDF]

PLoS One
Huang M, Li D, Xia Z, Liao S, Si W, Yuan C, Liao Y, Wu W, Jiang M, Yu X, Quan Y.   +10 more
europepmc   +1 more source

Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma

, 2016
Mina S. Ally, Katherine J. Ransohoff, Kavita Y. Sarin, Scott X. Atwood, Melika Rezaee, Irene Bailey, Jynho Kim, Philip A. Beachy, Anne Lynn S. Chang, Anthony E. Oro, Jean Y. Tang, A. Dimitrios Colevas   +11 more
openalex   +2 more sources

Combination therapy based on venetoclax overcomes resistance to all-trans retinoic acid and arsenic trioxide in a variant acute promyelocytic leukemia with TNRC18::RARA fusion. [PDF]

Ann Hematol
Ding W, Zhao J, Wang Z, Liu Y, Wang M, Shen H, Chen Y, Huang J, Li D, Chen S, Wen L.   +10 more
europepmc   +1 more source

Sensitivity of Platinum-Based Chemotherapy and Efficacy of Arsenic Trioxide-Based Non-Platinum Chemotherapy Following the Progression of PARPi Maintenance Therapy: A Real-World Study. [PDF]

Cancer Med
Gou R, Xie Q, Ren H, Zhang H, Wang T, Li Z, Li Z, Wang R, Yang Y, Shen X, Li Y, Wang Y, Wei L, Li X.   +13 more
europepmc   +1 more source

Hepatotoxicity induced by arsenic trioxide: clinical features, mechanisms, preventive and potential therapeutic strategies. [PDF]

Front Pharmacol
Wen J, Li A, Wang Z, Guo X, Zhang G, Litzow MR, Liu Q.   +6 more
europepmc   +1 more source

ALLG APML5: bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APL. [PDF]

Blood Adv
Iland HJ, Reynolds J, Boddy AV, Schultz HB, Khoo L, Fleming S, Lane SW, Weber N, Gasiorowski R, Armytage T, Harrup R, Watson AM, Tan P, Filshie R, Kwok F, Stevenson W, Yuen S, Ng AP, Rowley L, Marlton P, Wei AH.   +20 more
europepmc   +1 more source